MNA

French startup Terratis is curbing invasive tiger mosquito populations by releasing millions of X-ray-sterilized males into urban environments to disrupt the reproductive cycle. According to the Institute of Research for Development (IRD), the technique aims to collapse local populations by ensuring females lay infertile eggs. While currently limited to pilot trials, the method represents a growing global shift toward biological control as climate change accelerates the spread of disease-carrying insects.

How Does the Sterile Insect Technique Work?

The sterile insect technique relies on flooding a specific geography with millions of lab-reared, infertile males. According to Clelia Oliva, co-founder of Terratis, the process involves exposing batches of 400,000 male mosquitoes to X-rays. Once released into urban areas, these males compete with wild counterparts to mate. Because the males are sterile, the resulting eggs produced by wild females never hatch, gradually reducing the population size.

How Does Sterilization Compare to Wolbachia Infections?

While sterilization targets the population size, the Wolbachia method focuses on disease transmission. According to Frederic Simard, head of the IRD, the two methods serve different purposes. The Wolbachia approach involves infecting mosquitoes with bacteria that prevent them from carrying viruses, while sterilization is a population-suppression tool.

Simard notes that the Wolbachia technique acts as an “emergency response” to immediate health threats, whereas sterilization is viewed as a longer-term strategy. In Brazil, facilities utilizing the Wolbachia method produce upwards of 100 million eggs per week, showcasing the massive scale required for biological interventions.

What Are the Biggest Barriers to Scaling Up?

Scaling production remains the primary hurdle for wider adoption. Terratis currently produces 1.5 million sterile mosquitoes weekly, with a goal of reaching 40 million within two years. According to Simard, the industry is currently at an “iPhone 1.0” stage, meaning costs must drop and production must increase before the method can be considered sustainable for entire cities.

Financial responsibility also remains unresolved. Stephane Jouault, deputy mayor of Montpellier, stated that the current trial—costing approximately 70,000 euros—is not currently scalable at the municipal level. He argues that regional health agencies and the state must step in to fund city-wide deployments.

Regulatory and Legal Hurdles

Beyond funding, the industry faces a regulatory grey area. Because sterile mosquitoes are not classified as traditional biocides or genetically modified organisms (GMOs), private investment is often hesitant. This lack of clear classification complicates how local governments approve and integrate these programs into public health strategies.

Frequently Asked Questions

• Will this eliminate mosquitoes entirely? No. According to Terratis, the goal is to significantly and sustainably reduce population numbers rather than eradicate the species.
• Are these mosquitoes genetically modified? No. The sterilization process uses X-rays on standard mosquitoes, meaning they are not classified as GMOs.
• Are these releases safe for the public? Yes. The males released do not bite humans, as only female mosquitoes require blood meals to produce eggs.

Have you noticed an increase in mosquito activity in your area? Share your thoughts in the comments below or subscribe to our health newsletter for the latest updates on vector-borne disease control.